21369 - Virginia Cancer Specialists

Trial ID 21369

Sponsor ID PICCOLO

PICCOLO: A Phase 2, Single Arm Study of Mirvetuximab Soravtansine in Recurrent Platinum-Sensitive, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers with High Folate Receptor-Alpha Expression

Principal Investigator

Robert L. Marsh, MD

3 Locations

Gynecologic

Locations

Arlington Office

Fairfax Office

Gainesville Office

Learn More About This Trial

Name*
First Last
Diagnosis / Trial Interested In*
Email*
Enter Email Confirm Email
Comments
Phone
CAPTCHA

Other Relevant Trials

Trial ID 21308

Sponsor ID Zentalis Pharmaceuticals

A Phase 1/2 Dose-Escalation and Dose-Expansion Study of ZN‑c3 in Combination with Niraparib in Subjects with Platinum-Resistant Ovarian Cancer

Principal Investigator

Alexander I. Spira, MD, PhD, FACP

1 Location

Gynecologic

Trial ID 21253

Sponsor ID FLORA-5

A Phase 3, Double-Blind, Placebo-Controlled, Multicenter Clinical Study comparing Chemo-Immunotherapy (Paclitaxel-Carboplatin-Oregovomab) versus Chemotherapy (Paclitaxel-Carboplatin-Placebo) in Patients with Advanced Epithelial Ovarian, Fallopian Tube or Peritoneal Carcinoma(FLORA-5)